Is topical tacrolimus really an effective therapy for hailey-hailey disease? [1]

Archives of Dermatology

Volumn 140, Issue 10, 2004, Pages 1282-

  Laffitte, Emmanuel ^a   Panizzon, Renata G ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CALCIPOTRIOL; DICLOXACILLIN; ERYTHROMYCIN; STEROID; TACROLIMUS; VITAMIN D DERIVATIVE;

BURNING SENSATION; DISEASE EXACERBATION; DRUG CONTRAINDICATION; HAILEY HAILEY DISEASE; HUMAN; LETTER; MICROBIOLOGICAL EXAMINATION; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

ADMINISTRATION, CUTANEOUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PEMPHIGUS, BENIGN FAMILIAL; STAPHYLOCOCCAL SKIN INFECTIONS; TACROLIMUS;

EID: 5444244234     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Sand C, Thomsen HK. Topical tacrolimus ointment is an effective therapy for Hailey-Hailey disease. Arch Dermatol. 2003;139:1401-1402.
2. Rabeni EJ, Cunningham NM. Effective treatment of Hailey-Hailey disease with topical tacrolimus. J Am Acad Dermatol. 2002;47:797-798.
3. Fuchs M, Schliemann-Willers S, Heinemann C, Eisner P. Tacrolimus enhances irritation in a 5-day human irritancy in vivo model. Contact Dermatitis. 2002;46:290-294.
4. Shainhouse T, Eichenfield LF. Long-term safety of tacrolimus ointment in children treated for atopic dermatitis. Expert Opin Drug Saf. 2003;2:457-465.